» Non-Financial

Company Directors
Company Advisors
New & Press Releases
Directors Share Dealings
Major Shareholders
Company Subsidiary Calendar of Future Events
Company Name Change
Company Status Change

» Analyst Spreadsheet

Quick View(PDF)
Trader(PDF)
Dossier(PDF)
Download Analyst Template
Analyst Spreadsheet
Download Master Template
Annual Master Spreadsheet
Quarterly Master Spreadsheet
Annual & Quaterly Master Spreadsheet
Valuation Model Template
Valuation Model Spreadsheet
Business Risk(PDF)
Credit Metrics(PDF)
Annual Reports

For all products and/or service inquiries or to learn more about how WVB customer service solutions can reduce your service costs while increasing customer satisfaction, email us at .

PHARMARISE HOLDINGS

WVB Number : JPN000032937 Country : Japan
SIC categorization : DRUG & PROPRIETARY STORES (5912) ISIN : JP3802320006
FT categorization : DRUGS (433)  
Company status: ACTIVE  

» Corporation Profile :

Profile in brief:
The Company is a Japan-based holding company primarily engaged in the compounding medicine pharmacy businesses.
Phone : 81 03 3362 7130 Fax : 03 3362 7190
Chairman: : MASAYUKI AKIYAMA Auditor : GRANT THORNTON TAIYO LLC
CEO/Managing Director : KEIKO MATSUURA

» Company Facts

Net Profit Margin (%) 0.82  
Operating Margin (%) 2.44  
Return on Assets (%) 1.71  
Return on Equity (%) 6.96  
Employees 1,546  

» Company Financials

  Annual (2020)
Income Statement
('000 JPY )
Sales/Total Revenue 52,324,000  
EBITDA 2,591,000  
EBIT 836,000  
Net Income 427,000  
Balance Sheet
( '000 JPY)
Total Current Assets 10,546,000  
Total Assets 24,724,000  
Current Liabilities 9,392,000  
Total Liabilities & Debt 18,392,000  
Total Equity 6,332,000  
Cash & Flow
( '000 JPY)
Net Income/Staring Line 1,202,000  
Cash from Operating 1,944,000  
Cash from Investing -1,076,000  
Cash from Financing -728,000  
Cash & Equivalent Yr End 4,604,000